CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in CytomX Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- −18 vs. Q1 2022
- Shares held
- 45.6M
- −8.08M (−15.1%) vs. Q1 2022
- Total value
- $83.4M
- −$59.8M (−41.8%) vs. Q1 2022
- New holders
- 22
- 26 more added
- Sold out
- 40
- 29 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 178 | $799.0M |
| Q1 2026 | 179 | $911.2M |
| Q4 2025 | 122 | $613.9M |
| Q3 2025 | 103 | $438.4M |
| Q2 2025 | 83 | $302.6M |
| Q1 2025 | 66 | $28.8M |
| Q4 2024 | 70 | $48.1M |
| Q3 2024 | 69 | $60.4M |
| Q2 2024 | 74 | $61.9M |
| Q1 2024 | 88 | $97.1M |
| Q4 2023 | 68 | $50.6M |
| Q3 2023 | 62 | $41.8M |
| Q2 2023 | 67 | $58.7M |
| Q1 2023 | 76 | $53.7M |
| Q4 2022 | 81 | $57.5M |
| Q3 2022 | 84 | $52.6M |
| Q2 2022 | 99 | $83.4M |
| Q1 2022 | 119 | $143.4M |
| Q4 2021 | 110 | $236.5M |
| Q3 2021 | 114 | $274.8M |
| Q2 2021 | 122 | $358.9M |
| Q1 2021 | 126 | $422.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding CytomX Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Altium Capital Management LP | 0 | $0 | 0.00% | −663,800−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −242,100−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −200,943−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −167,178−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −138,123−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −106,900−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −87,671−100.0% | Sold out |
| Globeflex Capital L P | 0 | $0 | 0.00% | −69,435−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −68,259−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −67,376−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −67,211−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −62,800−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −60,992−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −49,700−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −45,449−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −41,535−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −38,145−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −32,200−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −31,400−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −30,027−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −27,558−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −25,786−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −25,634−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −23,628−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −21,698−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −21,209−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,061−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −18,904−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −17,692−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −14,530−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −14,630−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,591−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −10,811−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −10,528−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −10,184−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −8,372−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −5,010−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,708−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |